Workflow
晨光生物(300138) - 2020年10月27日投资者关系活动记录表-1
CCGBCCGB(SZ:300138)2022-12-04 06:50

Financial Performance - In the first three quarters of 2020, the company achieved operating income of 2.708 billion CNY, a year-on-year increase of 17.43% [2] - Net profit attributable to shareholders reached 206 million CNY, up 39.28% year-on-year [2] - In Q3 alone, operating income was 882 million CNY, with a year-on-year growth of 26.79% [2] - Q3 net profit attributable to shareholders was 53.604 million CNY, reflecting a 46.36% increase [2] - The overall gross profit margin for the first three quarters was 20.94%, an increase of 2.45% compared to the same period last year [3] Business Segments - Revenue from cottonseed business decreased from 43.84% to 41.06% of total revenue [4] - Plant extraction business revenue was 1.502 billion CNY, a year-on-year increase of 25.84% with a gross margin of 26.90% [4] - Revenue from chili red increased by 17% year-on-year, while chili extract revenue grew by 15% despite a 14% drop in sales volume [4] - Stevia sugar revenue surged by 123% year-on-year, driven by improved production processes [8] Research and Development - R&D expenses for the first three quarters amounted to 51.81 million CNY, a 55% increase year-on-year [5] - The company continues to focus on new variety development and customized products [5] Future Outlook - The company aims to increase market share of chili red to 66-80% and chili extract and lutein to 50-66% [6] - Plans to expand the planting area for lutein by approximately 50,000 mu this year [5] - The second-tier products are expected to maintain rapid growth, with stevia sugar and pepper extract showing significant potential [5] Investor Relations - The company actively engages with investors through various channels, including phone conferences and one-on-one communications [2] - The management addresses concerns regarding raw material price fluctuations and the impact of the pandemic on exports [7][8]